173 related articles for article (PubMed ID: 30141457)
1. Line Immunoassay: A Rapid Test for Screening TORCH Complex in Antenatal Patients with Bad Obstetric History.
Kumar H; Singh VA; Isha M; Mehta S; Garg R; Shinu P
Mymensingh Med J; 2018 Jul; 27(3):641-644. PubMed ID: 30141457
[TBL] [Abstract][Full Text] [Related]
2. TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China.
Wang LC; Yan F; Ruan JX; Xiao Y; Yu Y
BMC Pregnancy Childbirth; 2019 Dec; 19(1):484. PubMed ID: 31818265
[TBL] [Abstract][Full Text] [Related]
3. TORCH infection in women with bad obstetric history--a pilot study in Kumaon region.
Thapliyal N; Shukla PK; Kumar B; Upadhyay S; Jain G
Indian J Pathol Microbiol; 2005 Oct; 48(4):551-3. PubMed ID: 16366124
[TBL] [Abstract][Full Text] [Related]
4. Is screening of TORCH worthwhile in women with bad obstetric history: an observation from eastern Nepal.
Kumari N; Morris N; Dutta R
J Health Popul Nutr; 2011 Feb; 29(1):77-80. PubMed ID: 21528793
[TBL] [Abstract][Full Text] [Related]
5. TORCH serologies and specific IgM antibody determination in acquired and congenital infections.
Fung JC; Tilton RC
Ann Clin Lab Sci; 1985; 15(3):204-11. PubMed ID: 2986514
[TBL] [Abstract][Full Text] [Related]
6. Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women.
De Carolis S; Tabacco S; Rizzo F; Perrone G; Garufi C; Botta A; Salvi S; Benedetti Panici P; Lanzone A
Lupus; 2018 Apr; 27(5):841-846. PubMed ID: 29157179
[TBL] [Abstract][Full Text] [Related]
7. Standardization of an in-house multiplex real-time polymerase chain reaction for the simultaneous detection of
Rajendiran P; Saravanan N; Ramamurthy M; Sankar S; Aruliah R; Nandagopal B; Sridharan G
Indian J Public Health; 2021; 65(4):369-374. PubMed ID: 34975080
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia.
Al-Hakami AM; Paul E; Al-Abed F; Alzoani AA; Shati AA; Assiri MI; Qasim AA; Riaz F; Moosa RA; Chandramoorthy HC
Saudi Med J; 2020 Jul; 41(7):757-762. PubMed ID: 32601646
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of torch infections and its associated poor outcome in high-risk pregnant women of Central India: Time to think for prevention strategies.
Manjunathachar HV; Singh KN; Chouksey V; Kumar R; Sharma RK; Barde PV
Indian J Med Microbiol; 2020; 38(3 & 4):379-384. PubMed ID: 33154250
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of TORCH antibodies in the reproductive-aged women in China.
Qi Y; Zhu S; Li C; Wu H; Yue H; Zhang Y; Zhu B; Ma J; Feng Z; Kong H; Cai X; Ruan Q
Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():114-118. PubMed ID: 32957008
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence and Determinants of ToRCH Pathogens in Pregnant Women in the Sub-Himalayan Region.
Deka S; Kalita D; Paul M; Badoni G; Mathuria YP
Cureus; 2022 Feb; 14(2):e21946. PubMed ID: 35273887
[TBL] [Abstract][Full Text] [Related]
12. The Screening of
Nabizadeh E; Ghotaslou A; Salahi B; Ghotaslou R
Infect Dis Obstet Gynecol; 2022; 2022():4490728. PubMed ID: 35046632
[TBL] [Abstract][Full Text] [Related]
13. Protein arrays based on biotin-streptavidin system for the simultaneous detection of TORCH infections.
Jiang L; Yu Z; Tang Z; Jiang T; Zhang C; Lu Z
J Nanosci Nanotechnol; 2008 May; 8(5):2286-92. PubMed ID: 18572639
[TBL] [Abstract][Full Text] [Related]
14. Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay.
Chen L; Liu J; Shi L; Song Y; Song Y; Gao Y; Dong Y; Li L; Shen M; Zhai Y; Cao Z
J Clin Lab Anal; 2019 May; 33(4):e22828. PubMed ID: 30666721
[TBL] [Abstract][Full Text] [Related]
15. Immune status in congenital infections by TORCH agents in pregnant Thais.
Taechowisan T; Sutthent R; Louisirirotchanakul S; Puthavathana P; Wasi C
Asian Pac J Allergy Immunol; 1997 Jun; 15(2):93-7. PubMed ID: 9346273
[TBL] [Abstract][Full Text] [Related]
16. TORCH screening in polyhydramnios: an observational study.
Fayyaz H; Rafi J
J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1069-72. PubMed ID: 21923307
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Serum Antibodies to TORCH Infection in and Around Varanasi, Northern India.
Sen MR; Shukla BN; Tuhina B
J Clin Diagn Res; 2012 Nov; 6(9):1483-5. PubMed ID: 23285435
[TBL] [Abstract][Full Text] [Related]
18. Association between TORCH infection and lupus anticoagulant antibody in pregnant women with recurrent abortion.
Fatah HR
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):162-166. PubMed ID: 38158672
[TBL] [Abstract][Full Text] [Related]
19. ToRCH "co-infections" are associated with increased risk of abortion in pregnant women.
Rasti S; Ghasemi FS; Abdoli A; Piroozmand A; Mousavi SG; Fakhrie-Kashan Z
Congenit Anom (Kyoto); 2016 Mar; 56(2):73-8. PubMed ID: 26499091
[TBL] [Abstract][Full Text] [Related]
20. Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status.
Karacan M; Batukan M; Cebi Z; Berberoglugil M; Levent S; Kır M; Baksu A; Ozel E; Camlıbel T
Arch Gynecol Obstet; 2014 Dec; 290(6):1115-20. PubMed ID: 25027818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
